Survey: Oncologists Treat Women Over 69 With Adjuvant Radiotherapy After Lumpectomy For Early-stage Breast Cancer Despite Evidence Against Benefits.

Wednesday, October 11, 2017

Medscape (10/11, Harrison) reports a study published in the Annals Of Surgical Oncology in July found that “a large proportion of surgeons in the United States and even a good percentage of radiation oncologists still insist on treating women aged 70 years and older with adjuvant radiotherapy after they undergo lumpectomy for early-stage breast cancer,” in spite of “overwhelming evidence that adjuvant radiotherapy provides no survival benefit and very little protection against recurrence compared with no radiation.” A survey conducted in follow-up to the study revealed “that 40% of surgeons and 20% of radiation oncologists felt that omitting radiotherapy after lumpectomy was ‘unreasonable.’” In addition, “almost half of the surgeons surveyed were concerned about legal liability issues if radiotherapy were omitted and patients subsequently developed a local recurrence, as were about one quarter of radiation oncologists.” 

Patients May Be Less Likely To Choose Digital Breast Tomosynthesis Screening Mammography Because Of Potential Financial Considerations, Study Suggests.

Tuesday, October 10, 2017

HealthImaging (10/6, Thakar) reported that research suggests “patients are less likely to choose digital breast tomosynthesis screening mammography (DBTSM), despite more accurate results than traditional 2D mammography screening (2DSM), because of potential financial considerations.” The findings were published in the Journal of the American College of Radiology. 

Study Seeks To Determine Whether 3-D Mammography Reduces A Woman’s Risk Of Developing Life-Threatening Breast Cancer More Than 2-D.

Friday, October 6, 2017
DOT Med News (10/5, Fischer) reports that research will seek to “determine if 3-D mammography reduces a woman’s risk of developing life-threatening breast cancer more than 2-D.” According to DOT Med News, “The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI) have developed the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) to compare the two types of digital mammography in breast cancer screenings.”

Young Women Who Drink Spirits May Be More Likely To Develop Dense Breast Tissue Than Peers Who Drink Beer, Wine, Study Suggests.

Wednesday, October 4, 2017
HealthImaging (10/3, Pearson) reports that research suggests “young women who drink spirits – i.e., ‘hard liquor’ – may be more prone to developing dense breast tissue than their peers who either stick to beer and wine or don’t drink at all.” The findings were published online in Cancer Causes & Control. 

Study: Radiologists Conflicted About Additional Dense Breast Imaging.

Wednesday, October 4, 2017

Aunt Minnie (10/4, Yee) reports on a study in Academic Radiology which found that radiologists “remain conflicted about breast density notification legislation, whether to recommend supplemental imaging for women with dense breast tissue, and, if so, what kind of imaging is best.” The team led by “Dr. Ana Lourenco at Brown University found that only 66% of respondents to a survey of members of the New England Roentgen Ray Society felt that density notification legislation increased provider awareness about density’s effect on mammographic sensitivity.” Researchers wrote that their study “confirms that radiologists would benefit from further education about breast density laws, the clinical importance of dense breast tissue, and management of women with dense tissue.” The article adds, “a professional society guideline would be very helpful for both referring physicians and radiologists – and the American College of Radiology (ACR) is working on it, Lourenco said.”